MODULATION OF LIPOPROTEIN-LIPASE ACTIVITY IN THE RAT BY THE BETA-2-ADRENERGIC AGONIST CLENBUTEROL

被引:16
作者
BELAHSEN, R [1 ]
DESHAIES, Y [1 ]
机构
[1] UNIV LAVAL,SCH MED,DEPT PHYSIOL,QUEBEC CITY G1K 7P4,QUEBEC,CANADA
关键词
TRIGLYCERIDE; LIPOPROTEIN LIPASE; TISSUE SPECIFICITY; MEAL INTAKE; BETA-2-AGONIST;
D O I
10.1139/y92-223
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study evaluated the effects of beta2-adrenoceptor stimulation on some determinants of triglyceride metabolism. Male Sprague - Dawley rats were injected twice daily with clenbuterol (30 mug . kg-1) for 7 days, or with an equivalent volume of vehicle. Serum triglycerides, hepatic triglyceride secretion rate, and lipoprotein lipase activity in white and brown adipose tissues as well as in red vastus lateralis muscle and heart were evaluated in the fasting state and following a fat-free, high-sucrose meal, 3 h after the last agonist injection. In rats killed in the fasting and postprandial states, clenbuterol reduced the mass of white adipose tissue (-25 and -12%, respectively; p < 0.02), whereas it increased the mass of vastus lateralis muscle (+11 and +7%; p < 0.002) and heart (+13 and +10%; p < 0.0001). In vehicle-injected animals, the fasting state was associated with lower lipoprotein lipase activity in white and brown adipose tissues, and higher enzyme activity in vastus lateralis and heart, compared with the postprandial state. Postprandially, treatment with clenbuterol reduced lipoprotein lipase activity in white adipose (-24%), whereas it increased enzyme activity in brown adipose (+107%) as well as in vastus lateralis (+35%). In fasted animals, no significant variation of enzyme activity in these tissues was observed following clenbuterol treatment, whereas in the heart, a decrease of lipoprotein lipase activity was observed (-22%). Clenbuterol lowered serum triglycerides significantly (-23%), but not their rate of secretion, whereas the agonist decreased the insulin to glucagon ratio only in the postprandial state. These results suggest that modulation of triglyceride-rich lipoprotein metabolism, particularly tissue-specific alterations in lipoprotein lipase activity, may be one of the pathways through which clenbuterol affects partitioning of lipid substrates.
引用
收藏
页码:1555 / 1562
页数:8
相关论文
共 47 条
[41]   STIMULATION OF MUSCLE GROWTH BY CLENBUTEROL - LACK OF EFFECT ON MUSCLE PROTEIN-BIOSYNTHESIS [J].
REEDS, PJ ;
HAY, SM ;
DORWOOD, PM ;
PALMER, RM .
BRITISH JOURNAL OF NUTRITION, 1986, 56 (01) :249-258
[42]   CHANGES IN TISSUE BLOOD-FLOW AND BETA-RECEPTOR DENSITY OF SKELETAL-MUSCLE IN RATS TREATED WITH THE BETA-2-ADRENOCEPTOR AGONIST CLENBUTEROL [J].
ROTHWELL, NJ ;
STOCK, MJ ;
SUDERA, DK .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (03) :601-607
[43]   INCREASED BODY-WEIGHT GAIN AND BODY PROTEIN IN CASTRATED AND ADRENALECTOMIZED RATS TREATED WITH CLENBUTEROL [J].
ROTHWELL, NJ ;
STOCK, MJ .
BRITISH JOURNAL OF NUTRITION, 1988, 60 (02) :355-360
[44]   SHORT-TERM INCUBATION OF CARDIAC MYOCYTES WITH ISOPRENALINE HAS NO EFFECT ON HEPARIN-RELEASABLE OR CELLULAR LIPOPROTEIN-LIPASE ACTIVITY [J].
SEVERSON, DL ;
CARROLL, R ;
KRYSKI, A ;
RAMIREZ, I .
BIOCHEMICAL JOURNAL, 1987, 248 (01) :289-292
[45]   EXPRESSION OF LIPOPROTEIN-LIPASE MESSENGER-RNA IN RAT-HEART IS LOCALIZED MAINLY TO MESENCHYMAL CELLS AS STUDIED BY INSITU HYBRIDIZATION [J].
STEIN, O ;
STEIN, Y ;
SCHWARTZ, SP ;
RESHEF, A ;
CHAJEKSHAUL, T ;
BENNAIM, M ;
FRIEDMAN, G ;
LEITERSDORF, E .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (04) :857-863
[46]  
WOODSIDE WF, 1987, J CARDIOVASC PHARM, V10, pS27
[47]   SLOW TO FAST ALTERATIONS IN SKELETAL-MUSCLE FIBERS CAUSED BY CLENBUTEROL, A BETA-2-RECEPTOR AGONIST [J].
ZEMAN, RJ ;
LUDEMANN, R ;
EASTON, TG ;
ETLINGER, JD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (06) :E726-E732